Drug Shortage Report for SANDOZ RIZATRIPTAN ODT

Last updated on 2021-11-30 History
Report ID 149880
Drug Identification Number 02351889
Brand name SANDOZ RIZATRIPTAN ODT
Common or Proper name RIZATRIPTAN ODT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) RIZATRIPTAN
Strength(s) 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL ORAL
Packaging size 6ODT UD
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-24
Estimated end date 2021-12-03
Actual end date 2021-11-29
Shortage status Resolved
Updated date 2021-11-30
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2021-11-30 English Compare
v5 2021-11-29 French Compare
v4 2021-11-29 English Compare
v3 2021-11-24 French Compare
v2 2021-11-24 English Compare
v1 2021-11-24 English Compare